Share Price:

APNASPENAspen Pharmacare Hldgs22979-195 (-0.84%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa.

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to announce that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA Operations”), has concluded a ten-year agreement (“the Agreement”) with Serum Institute of India Pvt Ltd (“the Serum Institute”), the world’s largest vaccine producer,… Continue reading Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa.

Aspen’s response to Monkeypox being declared a Public Health Emergency of International Concern by WHO

Durban – JSE listed company Aspen Pharmacare Holdings Limited (Aspen), a global multinational specialty pharmaceutical company, is positively positioned to respond as a third party for capacity fill opportunities following the World Health Organisation’s (WHO) declaration of monkeypox being a Public Health Emergency of International Concern (PHEIC). This declaration is the first since that announced… Continue reading Aspen’s response to Monkeypox being declared a Public Health Emergency of International Concern by WHO

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.